Kleem Chaudhary serves as Executive at Checkmate Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Kleem Chaudhary has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 26, 2021 involved exercising options for 2,000 shares valued at $5.2K.
Kleem Chaudhary currently holds 8,000 shares of Checkmate Pharmaceuticals, Inc. (CMPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kleem Chaudhary has been a net neutral trader of CMPI stock. They have purchased $0 and sold $0 worth of shares.
Kleem Chaudhary's most recent insider trade was on Feb 26, 2021, when they sold 2,000 shares at $2.62 per share.
Get notified when new Form 4 filings are submitted
| 2,000 |
| $2.62 |
| Discretionary |
| Dec 22, 2020 | CMPI | $10.5K | Option Exercise | 4,000 | $2.62 | Discretionary |